We are live on ! Find out more
IMMU

Immunomedics Inc
IMMU

Delisted

IMMU was delisted on the 22nd of October, 2020.

Back to rankings

83 hedge funds and large institutions have $208M invested in Immunomedics Inc in 2013 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 28 increasing their positions, 28 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

71% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 7

52% more call options, than puts

Call options by funds: $15M | Put options by funds: $9.83M

29% more capital invested

Capital invested by funds: $162M → $208M (+$46.8M)

5% more funds holding

Funds holding: 79 → 83 (+4)

0% more repeat investments, than reductions

Existing positions increased: 28 | Existing positions reduced: 28

Holders
83
Holders Change
+4
Holders Change %
+5.06%
% of All Funds
2.69%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
12
Increased
28
Reduced
28
Closed
7
Calls
$15M
Puts
$9.83M
Net Calls
+$5.16M
Net Calls Change
+$4.44M

Top Buyers

Rank Fund Capital Flow
1
SCA
SAC Capital Advisors
Connecticut
+$10.4M
2
SCM
Sigma Capital Management
Connecticut
+$7.92M
3
Fidelity Investments
Fidelity Investments
Massachusetts
+$5.76M
4
BFA
BlackRock Fund Advisors
California
+$2.19M
5
Renaissance Technologies
Renaissance Technologies
New York
+$1.5M

Top Sellers

Rank Fund Capital Flow
1
OAM
Oxford Asset Management
United Kingdom
-$1.37M
2
B
Bailard
California
-$1.33M
3
GCP
GSA Capital Partners
United Kingdom
-$1.22M
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$1.07M
5
Charles Schwab
Charles Schwab
California
-$593K
Name Holding Trade Value Shares
Change 		Change in
Stake
TRCT
76
Tower Research Capital (TRC)
New York
$14K +$1.34K +232 +12%
BlackRock
77
BlackRock
New York
$13K – – –
PSUF
78
People's United Financial
Connecticut
$12K – – –
ST
79
Spot Trading
Illinois
$12K +$6.91K +1,201 +181%
Royal Bank of Canada
80
Royal Bank of Canada
Ontario, Canada
$7K +$5.98K +1,039 +2,598%
WAM
81
Wolverine Asset Management
Illinois
$4K – – –
MI
82
Markston International
New York
$2K -$777 -135 -31%
Manulife (Manufacturers Life Insurance)
83
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$363 -$10.3K -1,787 -3%
OAM
84
Oxford Asset Management
United Kingdom
– -$1.37M -251,955 Closed
ARTA
85
A.R.T. Advisors
New York
– -$472K -86,905 Closed
EMG
86
Ellington Management Group
Connecticut
– -$468K -86,000 Closed
Nomura Holdings
87
Nomura Holdings
Japan
– -$199K -36,595 Closed
MA
88
MUFG Americas
New York
– -$163K -30,000 Closed
Jane Street
89
Jane Street
New York
– -$110K -20,264 Closed
FNYS
90
First New York Securities
New York
– -$27K -4,990 Closed
1 2 3
4

IMMU Hedge Fund Activity: Q3 2013 in Review

83 of the 3,085 institutional investors tracked by Wall St. Rank reported a position in Immunomedics Inc (IMMU) for Q3 2013, worth a combined $208M — up 29% from $162M a quarter earlier.

Buyers outnumbered sellers: 12 funds opened new IMMU positions and 7 closed out — a net gain of 5 holders — while 28 added to existing stakes and 28 trimmed.

The largest buyer was SAC Capital Advisors, opening a new position worth an estimated $10.4M. The largest seller was Oxford Asset Management, exiting entirely with an estimated $1.37M sold.

  • 83 institutional investors held Immunomedics Inc (IMMU) as of Q3 2013, up from 79 in Q2 2013.
  • Funds reported $208M of Immunomedics Inc stock for Q3 2013, up 29% quarter-over-quarter.
  • 12 funds opened new Immunomedics Inc positions in Q3 2013 and 7 closed out, a net change of +5 holders.
  • The largest Immunomedics Inc buyer in Q3 2013 was SAC Capital Advisors, an estimated $10.4M added.
  • The largest Immunomedics Inc seller in Q3 2013 was Oxford Asset Management, an estimated $1.37M sold.

Based on aggregated 13F filings for Q3 2013.